CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹258 Cr | ₹92 Cr | ₹247 Cr | ₹520 Cr | ₹824 Cr |
What is the latest Total Debt ratio of CIPLA ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹258 Cr |
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹247 Cr |
| Mar2023 | ₹520 Cr |
| Mar2022 | ₹824 Cr |
How is Total Debt of CIPLA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹258 Cr | 180.10 | |
| Mar2025 | ₹92 Cr | -62.72 | |
| Mar2024 | ₹247 Cr | -52.53 | |
| Mar2023 | ₹520 Cr | -36.86 | |
| Mar2022 | ₹824 Cr | - | |
Compare Total Debt of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹112,879.8 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| MANKIND PHARMA | ₹102,247.0 Cr | 1.9% | 3.5% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.9% |
-0.8% |
-10.9% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses